Chinook Therapeutics Price Prediction

KDNYDelisted Stock  USD 39.25  0.20  0.51%   
At this time The value of RSI of Chinook Therapeutics' share price is above 80 . This indicates that the stock is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

85

 
Oversold
 
Overbought
The successful prediction of Chinook Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Chinook Therapeutics, which may create opportunities for some arbitrage if properly timed.
Using Chinook Therapeutics hype-based prediction, you can estimate the value of Chinook Therapeutics from the perspective of Chinook Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Chinook Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Chinook because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Chinook Therapeutics after-hype prediction price

    
  USD 39.25  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Intrinsic
Valuation
LowRealHigh
29.0129.0143.18
Details
Naive
Forecast
LowNextHigh
41.8541.8541.85
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
38.8739.1439.40
Details

Chinook Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Chinook Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Chinook Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Chinook Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Chinook Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Chinook Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Chinook Therapeutics' historical news coverage. Chinook Therapeutics' after-hype downside and upside margins for the prediction period are 39.25 and 39.25, respectively. We have considered Chinook Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
39.25
39.25
After-hype Price
39.25
Upside
Chinook Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Chinook Therapeutics is based on 3 months time horizon.

Chinook Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Chinook Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chinook Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Chinook Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
2 Events / Month
15 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
39.25
39.25
0.00 
0.00  
Notes

Chinook Therapeutics Hype Timeline

Chinook Therapeutics is now traded for 39.25. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Chinook is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Chinook Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 39.25. About 97.0% of the company shares are owned by institutional investors. The book value of Chinook Therapeutics was now reported as 5.32. The company recorded a loss per share of 3.24. Chinook Therapeutics last dividend was issued on the 2nd of October 2020. The entity had 1:5 split on the 2nd of October 2020. Given the investment horizon of 90 days the next estimated press release will be in a few days.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Chinook Therapeutics Related Hype Analysis

Having access to credible news sources related to Chinook Therapeutics' direct competition is more important than ever and may enhance your ability to predict Chinook Therapeutics' future price movements. Getting to know how Chinook Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Chinook Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
DICEDice Molecules Holdings 0.02 7 per month 1.14  0.10  5.66 (2.91) 37.64 
PLRXPliant Therapeutics 0.22 9 per month 3.19 (0.01) 5.37 (5.55) 24.35 
CRNXCrinetics Pharmaceuticals 1.32 9 per month 2.43 (0.01) 3.67 (3.45) 16.75 
ASNDAscendis Pharma AS(2.73)9 per month 0.00 (0.05) 4.75 (3.56) 22.16 
VTYXVentyx Biosciences(0.07)7 per month 0.00 (0.05) 6.94 (5.86) 16.88 
NUVLNuvalent 0.63 10 per month 2.69  0.03  3.84 (4.61) 36.85 
CERECerevel Therapeutics Holdings 0.20 9 per month 0.94 (0.04) 1.91 (1.59) 6.40 
TVTXTravere Therapeutics(0.30)11 per month 1.93  0.23  11.58 (4.13) 23.97 
GPCRStructure Therapeutics American 2.89 9 per month 0.00 (0.07) 8.18 (6.07) 24.50 
RNAAvidity Biosciences 0.67 11 per month 4.19  0  5.78 (7.08) 27.94 
RVMDRevolution Medicines 1.13 10 per month 2.04  0.13  4.81 (3.24) 10.95 
DAWNDay One Biopharmaceuticals 0.23 9 per month 0.00 (0.07) 3.84 (3.69) 11.44 
SWTXSpringWorks Therapeutics(1.08)10 per month 0.00 (0.05) 4.86 (4.36) 12.80 
ACLXArcellx 6.42 10 per month 2.81  0.1  6.28 (5.68) 15.13 
PCVXVaxcyte 3.46 11 per month 2.18  0.04  3.32 (4.09) 42.81 
VRDNViridian Therapeutics 0.44 10 per month 3.45  0.1  6.84 (5.29) 44.89 
KALVKalvista Pharmaceuticals 0.34 8 per month 0.00 (0.08) 6.50 (6.22) 31.70 
THRXTheseus Pharmaceuticals 0.14 2 per month 0.00 (0.06) 11.75 (8.57) 90.33 
KURAKura Oncology(0.57)7 per month 0.00 (0.17) 4.98 (4.04) 42.52 

Chinook Therapeutics Additional Predictive Modules

Most predictive techniques to examine Chinook price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Chinook using various technical indicators. When you analyze Chinook charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Chinook Therapeutics Predictive Indicators

The successful prediction of Chinook Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Chinook Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Chinook Therapeutics based on analysis of Chinook Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Chinook Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chinook Therapeutics's related companies.

Story Coverage note for Chinook Therapeutics

The number of cover stories for Chinook Therapeutics depends on current market conditions and Chinook Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Chinook Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Chinook Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Chinook Therapeutics Short Properties

Chinook Therapeutics' future price predictability will typically decrease when Chinook Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Chinook Therapeutics often depends not only on the future outlook of the potential Chinook Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chinook Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding64.4 M
Cash And Short Term Investments378.3 M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Chinook Stock

If you are still planning to invest in Chinook Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chinook Therapeutics' history and understand the potential risks before investing.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account